Establishment of an anti-hepatitis C virus IgG avidity test for dried serum/plasma spots
Amare Eshetu(Robert Koch Institute), Norbert Bannert(Robert Koch Institute), Robert Ehret(University of Cologne), Viviane Bremer(Robert Koch Institute), Daniel Schmidt(Robert Koch Institute), Martin Obermeier(Max Planck Institute for Informatics), Andrea Hauser(Robert Koch Institute), Karolin Meixenberger(Robert Koch Institute), C.–Thomas Bock(Robert Koch Institute), Matthias an der Heiden(Robert Koch Institute), Stefan Roß(University of Duisburg-Essen), Barbara Gunsenheimer‐Bartmeyer(Robert Koch Institute)
Cited by 1
Related Papers
Epidemic Profile of Shiga-Toxin–Producing<i>Escherichia coli</i>O104:H4 Outbreak in Germany
|New England Journal of Medicine|2011|1.1k
German Outbreak of<i>Escherichia coli</i>O104:H4 Associated with Sprouts
|New England Journal of Medicine|2011|718
Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020
|Eurosurveillance|2020|238
Trouble with Bleeding: Risk Factors for Acute Hepatitis C among HIV-Positive Gay Men from Germany—A Case-Control Study
|PLoS ONE|2011|150
European all-cause excess and influenza-attributable mortality in the 2017/18 season: should the burden of influenza B be reconsidered?
|Clinical Microbiology and Infection|2019|140